LADENBURG THALMANN FINANCIAL SERVICES INC. - BIOPHARMX CORP ownership

BIOPHARMX CORP's ticker is BPMX and the CUSIP is 09072X101. A total of 23 filers reported holding BIOPHARMX CORP in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of BIOPHARMX CORP
ValueSharesWeighting
Q1 2019$4,000
-20.0%
42,2000.0%0.00%
Q4 2018$5,000
-58.3%
42,200
-34.3%
0.00%
Q3 2018$12,000
-20.0%
64,2000.0%0.00%
Q2 2018$15,0000.0%64,2000.0%0.00%
Q1 2018$15,000
+114.3%
64,2000.0%0.00%
Q4 2017$7,000
+16.7%
64,200
+190.5%
0.00%
Q3 2017$6,000
-45.5%
22,1000.0%0.00%
Q2 2017$11,000
+83.3%
22,100
+100.9%
0.00%
Q1 2017$6,000
+50.0%
11,0000.0%0.00%
Q4 2016$4,000
-33.3%
11,0000.0%0.00%
Q3 2016$6,000
-14.3%
11,0000.0%0.00%
Q2 2016$7,000
-41.7%
11,0000.0%0.00%
Q1 2016$12,00011,0000.00%
Other shareholders
BIOPHARMX CORP shareholders Q2 2018
NameSharesValueWeighting ↓
Vivo Capital, LLC 12,814,286$6,471,0001.90%
RTW INVESTMENTS, LP 1,283,951$648,0000.17%
Sio Capital Management, LLC 313,717$158,0000.09%
DAFNA Capital Management LLC 115,000$58,0000.05%
FIRST WILSHIRE SECURITIES MANAGEMENT INC 28,027$14,0000.00%
Baker Brothers Advisors 377,295$191,0000.00%
Virtu KCG Holdings LLC 107,994$55,0000.00%
FRANKLIN RESOURCES INC 9,499,615$4,797,0000.00%
Moors & Cabot, Inc. 13,000$7,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 17,274$8,0000.00%
View complete list of BIOPHARMX CORP shareholders